News

A landmark study by Roger Barker and collaborators shows that transplanting stem-cell derived dopamine progenitor cells into the brain to treat Parkinson’s disease is feasible. Eight patients were transplanted in the first clinical trial, and no serious side effects linked to the transplanted cells were seen during the first year of follow‑up. In P…

This week, the new members and associate members have been announced to the European Molecular Biology Organisation (EMBO). Professor Ragnhildur Thóra Káradóttir has been announced as one of the new members for 2026.The new cohort consists of 71 life scientists from 23 countries who will join the global community of 2,200 scientists. Professor Kára…

The Advanced Research and Invention Agency (ARIA) announced new funding this week, awarding new CSCI Group Leader Dr Chiara Herzog £5.79 million for her work on a project in the Sustained Viral Resilience programme.Dr Herzog will lead the epiPRIME project (Epigenetically Programmed Resilience through Innate Memory Engineering), collaborating with h…

Last Thursday and Friday, the Institute held the CSCI Annual Retreat & Symposium on 4 and 5 June in Cambridge.Our annual event brings together the stem cell research community for a day and a half of talks, posters, Institute updates, and networking outside of the office and labs. This year, we also featured a special afternoon talk and panel sessi…

The Academy of Medical Sciences has announced its latest cohort of Fellows today (21 May), welcoming Professor George Vassiliou as one of its exceptional new members. Professor Vassiliou is one of seven recognised from the University of Cambridge, and one of 60 new members overall in the awards that celebrate the work of scientists who have made ou…

Last week, the Cambridge Stem Cell Institute Technology & Innovation Forum (SCI-TIF) celebrated its 4th Annual Networking Dinner at Selwyn College, Cambridge. This event brings together our leading scientists from CSCI and our partners in the industry world. This year, conversations centred around growing alignment with human-relevant models and th…

Damage to white matter in the brain can trigger features associated with neurodegenerative disease, Cambridge researchers have discovered in a new study published today in the journal Nature.Until now, it was thought that neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease were primarily associated with changes to the brain’s gre…

A multi-centre team of investigators have identified critical neurons in the grey matter, the “thinking” portion of the brain, that are especially prone to DNA damage as neurological disease-related inflammation progresses.The findings, stemming from two complementary studies published this week in Nature, could lead to therapies to protect the bra…

Scientists from the Alcolea Group at the Cambridge Stem Cell Institute and collaborators at PDN have shown that when tumours first emerge, interactions with healthy cells in the underlying supportive tissue determine their ability to survive, grow, and progress to advanced stages of disease.The study, carried out in mice and further validated using…

The Hodson Group and collaborators have developed a customised blood test that can predict, more accurately than standard scans, whether treatment has successfully eradicated diffuse large B-cell lymphoma (DLBCL).DLBCL is the most common form of aggressive non-Hodgkin lymphoma, and is typically treated with a combination of chemotherapy and the ant…

The collaboration, announced last month, will use state-of-the-art genomics approaches in combination with machine learning methods to advance our scientific understanding of cells and tissues in health and disease.GSK is investing nearly £10 million in this ground-breaking alliance that brings together the expertise of world-leading researchers fr…

On Friday 5 December, CSCI celebrated our fourth annual Christmas Market at the Jeffrey Cheah Biomedical Centre. Partnering with our neighbours at Cancer Research UK Cambridge Institute, Cambridge Biomedical Campus, The Milner Therapeutics Institute, and Cambridge Institute of Therapeutic Immunology & Infectious Disease, the building welcomed over …

Professor Sarah Teichmann (Chair in Stem Cell Medicine, Cambridge Stem Cell Institute, Department of Medicine, University of Cambridge) has been elected to the prestigious National Academy of Medicine in the USA. She was announced as one of 90 new regular members and 10 new international members during the annual meeting in Washington yesterday (20…

Stem Cell Reports, the official journal of the International Society for Stem Cell Research, has just welcomed Cambridge Stem Cell Institute Director Bertie Göttgens as one of 13 new distinguished researchers to the Editorial Board. The new appointments are designed to broaden representation across the international landscape of stem cell science a…

A groundbreaking study led by Professor George Vassiliou at the Cambridge Stem Cell Institute and University of Cambridge has revealed that age-related telomere shortening plays a key role in the development of clonal haematopoiesis (CH) and blood cancers driven by mutations in RNA splicing genes. The findings, published this week in Nature Genetic…